참고문헌
- Barney BM, Petersen IA, Mariani A, et al (2013). The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer. Int J Radiat Oncol Biol Phys, 85, 109-15. https://doi.org/10.1016/j.ijrobp.2012.03.011
- Benedetti Panici P, Basile S, Maneschi F, et al (2008). Systematic pelvic lymphadenectomy vs. no lymphadenectomy in earlystage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst, 100, 1707-16. https://doi.org/10.1093/jnci/djn397
- Bjorge T, Engeland A, Tretli S, Weiderpass E (2007). Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. Int J Cancer, 120, 378-83. https://doi.org/10.1002/ijc.22260
- Boruta DM, Gehrig PA, Fader AN, Olawaiye AB (2009). Management of women with uterine papillary serous cancer: A Society of Gynecologic Oncology (SGO) review. Gynecologic Oncol, 115, 142-53. https://doi.org/10.1016/j.ygyno.2009.06.011
- Chan JK, Cheung MK, Huh WK, et al (2006). Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer, 107, 1823-30. https://doi.org/10.1002/cncr.22185
- Chang-Halpenny CN, Natarajan S, Hwang-Graziano J (2013). Early stage papillary serous or clear cell carcinoma confined to or involving an endometrial polyp: outcomes with and without adjuvant therapy. Gynecol Oncol, 131, 598-603. https://doi.org/10.1016/j.ygyno.2013.10.010
- Creasman WT, Odicino F, Maisonneuve P, et al (2006). Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet, 95, 105-43. https://doi.org/10.1016/S0020-7292(06)60031-3
- Desai NB, Kiess AP, Kollmeier MA, et al (2013). Patterns of relapse in stage I-II uterine papillary serous carcinoma treated with adjuvant intravaginal radiation (IVRT) with or without chemotherapy. Gynecol Oncol, 131, 604-8. https://doi.org/10.1016/j.ygyno.2013.09.019
- Fader AN, Boruta D, Olawaiye AB, Gehrig PA (2010). Uterine papillary serous carcinoma: epidemiology, pathogenesis and management. Curr Opin Obstet Gynecol, 22, 21-9. https://doi.org/10.1097/GCO.0b013e328334d8a3
- Ferlay J, Shin HR, Bray F, et al (2008). "GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer.
- Gehrig PA, Van Le L, Fowler WC Jr (2003). The role of omentectomy during the surgical staging of uterine serous carcinoma. Int J Gynecol Cancer, 13, 212-5.
- Hamilton CA, Cheung MK, Osann K, et al (2006). Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Br J Cancer, 94, 642-6.
- Jhingran A, Ramondetta LM, Bodurka DC, et al (2013). A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometrium. Gynecol Oncol, 129, 304-9. https://doi.org/10.1016/j.ygyno.2013.01.025
- Kelly MG, O'Malley D M, Hui P, et al (2005). Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy. Gynecol Oncol, 98, 353-9. https://doi.org/10.1016/j.ygyno.2005.06.012
- Khunhaprema T, Attasara P, Sriplung H, et al (2012). Cancer in Thailand. Volume VI, 2004-2006. Bangkok, National Cancer Institute, Department od Medical Service, Ministry of Public Health.
- Kim HJ, Kim TJ, Lee YY, et al (2013). A comparison of uterine papillary serous, clear cell carcinomas, and grade 3 endometrioid corpus cancers using 2009 FIGO staging system. J Gynecol Oncol, 24, 120-7. https://doi.org/10.3802/jgo.2013.24.2.120
- Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK (2009). Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet, 373, 125-36. https://doi.org/10.1016/S0140-6736(08)61766-3
- Olawaiye AB, Boruta DM (2009). Management of women with clear cell endometrial cancer A Society of Gynecologic Oncology (SGO) review. Gynecologic Oncology, 113, 277-83. https://doi.org/10.1016/j.ygyno.2009.02.003
- Siegel R, Naishadham D and Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30. https://doi.org/10.3322/caac.21166
- Slomovitz BM, Burke TW, Eifel PJ, et al (2003). Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases. Gynecol Oncol, 91, 463-9. https://doi.org/10.1016/j.ygyno.2003.08.018
- Todo Y, Kato H, Kaneuchi M, et al (2010). Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet, 376, 1165-72.
- Wilairat W, Benjapibal M (2012). Presence of anemia and poor prognostic factors in patients with endometrial carcinoma. Asian Pac J Cancer Prev, 13, 3187-90. https://doi.org/10.7314/APJCP.2012.13.7.3187
- Wilson TO, Podratz KC, Gaffey TA, et al (1990). Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma. Am J Obstet Gynecol, 162, 418-23. https://doi.org/10.1016/0002-9378(90)90399-R
피인용 문헌
- Comparison of Myometrial Invasion and Tumor Free Distance from Uterine Serosa in Endometrial Cancer vol.16, pp.2, 2015, https://doi.org/10.7314/APJCP.2015.16.2.519